Rabenaaf 20 

Presentation: Each enteric-coated capsule contains Rabeprazole Sodium BP 20 mg. Rabenaaf is a brand name marketed by Naafco Pharma Ltd. in Bangladesh. It is usually available in blister packs. The enteric coating helps to protect the medication from stomach acid, releasing it in the intestine.

Indications: Rabenaaf (Rabeprazole) is a proton pump inhibitor indicated for the treatment of:  

• Active duodenal ulcer  
• Active benign gastric ulcer  
• Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD)  
• Long-term management of GERD (GERD maintenance)
• Symptomatic treatment of moderate to very severe GERD  
• Zollinger-Ellison Syndrome  
• In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pyloriin patients with peptic ulcerdisease.

Dosage and Administration: The recommended oral dose is 20 mg once daily in the morning for active duodenal ulcer and active benign gastric ulcer. Most patients with active duodenal ulcer heal within four weeks, but some may require an additional four weeks. Most patients with active benign gastric ulcer heal within six weeks, with some needing an additional six weeks. For erosive or ulcerative GERD, the dose is 20 mg once daily for four to eight weeks. For long-term GERD management, a maintenance dose of 20 mg or 10 mg once daily can be used based on patient response. For symptomatic GERD without oesophagitis, the dose is 10 mg once daily. For Zollinger-Ellison Syndrome, the starting dose is 60 mg once daily, which may be adjusted up to 120 mg/day. For H. pylori eradication, Rabeprazole 20 mg is given twice daily with specific antibiotics (e.g., amoxicillin and clarithromycin) for 7 days.

Rabenaaf capsules should be swallowed whole and taken in the morning, before eating. Patients should be cautioned not to chew or crush the capsules. For duodenal ulcers, it is sometimes recommended to take it after the morning meal. For H. pylori eradication, it is usually taken with morning and evening meals along with antibiotics. Always follow your physician's specific instructions.

Side Effects: Common side effects may include headache, diarrhea, abdominal pain, nausea, vomiting, flatulence, constipation, dry mouth, and dizziness. Less common side effects can include insomnia, nervousness, and rash. Long-term use may be associated with an increased risk of bone fractures, low magnesium levels, and vitamin B12 deficiency in some individuals.

Precautions: Rabenaaf (Rabeprazole) is contraindicated in patients with known hypersensitivity to rabeprazole or other proton pump inhibitors. Gastric malignancy should be excluded before initiating therapy. Caution should be exercised in patients with severe hepatic impairment.

Use in Pregnancy and Lactation: Rabeprazole is not recommended during pregnancy or nursing.

Storage: Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.